Matches in Wikidata for { <http://www.wikidata.org/entity/Q72101958> ?p ?o ?g. }
Showing items 1 to 99 of
99
with 100 items per page.
- Q72101958 description "article scientifique publié en 1993" @default.
- Q72101958 description "artikull shkencor i botuar më 01 janar 1993" @default.
- Q72101958 description "artículu científicu espublizáu en xineru de 1993" @default.
- Q72101958 description "im Januar 1993 veröffentlichter wissenschaftlicher Artikel" @default.
- Q72101958 description "scientific article published on 01 January 1993" @default.
- Q72101958 description "wetenschappelijk artikel" @default.
- Q72101958 description "наукова стаття, опублікована в січні 1993" @default.
- Q72101958 name "Postmenopausal patients with node-positive resectable breast cancer. Tamoxifen vs FEC 50 (6 cycles) vs FEC 50 (6 cycles) plus tamoxifen vs control--preliminary results of a 4-arm randomised trial. The French Adjuvant Study Group" @default.
- Q72101958 name "Postmenopausal patients with node-positive resectable breast cancer. Tamoxifen vs FEC 50 (6 cycles) vs FEC 50 (6 cycles) plus tamoxifen vs control--preliminary results of a 4-arm randomised trial. The French Adjuvant Study Group" @default.
- Q72101958 name "Postmenopausal patients with node-positive resectable breast cancer. Tamoxifen vs FEC 50" @default.
- Q72101958 type Item @default.
- Q72101958 label "Postmenopausal patients with node-positive resectable breast cancer. Tamoxifen vs FEC 50 (6 cycles) vs FEC 50 (6 cycles) plus tamoxifen vs control--preliminary results of a 4-arm randomised trial. The French Adjuvant Study Group" @default.
- Q72101958 label "Postmenopausal patients with node-positive resectable breast cancer. Tamoxifen vs FEC 50 (6 cycles) vs FEC 50 (6 cycles) plus tamoxifen vs control--preliminary results of a 4-arm randomised trial. The French Adjuvant Study Group" @default.
- Q72101958 label "Postmenopausal patients with node-positive resectable breast cancer. Tamoxifen vs FEC 50" @default.
- Q72101958 prefLabel "Postmenopausal patients with node-positive resectable breast cancer. Tamoxifen vs FEC 50 (6 cycles) vs FEC 50 (6 cycles) plus tamoxifen vs control--preliminary results of a 4-arm randomised trial. The French Adjuvant Study Group" @default.
- Q72101958 prefLabel "Postmenopausal patients with node-positive resectable breast cancer. Tamoxifen vs FEC 50 (6 cycles) vs FEC 50 (6 cycles) plus tamoxifen vs control--preliminary results of a 4-arm randomised trial. The French Adjuvant Study Group" @default.
- Q72101958 prefLabel "Postmenopausal patients with node-positive resectable breast cancer. Tamoxifen vs FEC 50" @default.
- Q72101958 P1433 Q72101958-EB18F938-441C-4065-8194-8F983F5E0BD9 @default.
- Q72101958 P1476 Q72101958-776CD17A-E8DE-46AF-A3B2-578359AAD4CB @default.
- Q72101958 P2093 Q72101958-142F45C3-7719-43FC-A3B1-7B31C2A330F2 @default.
- Q72101958 P2093 Q72101958-1FD3C80D-55D4-4F83-AC15-9D38362CAEC4 @default.
- Q72101958 P2093 Q72101958-311AEE88-4A88-4FC3-89BA-F9EBA314C775 @default.
- Q72101958 P2093 Q72101958-4D5EE65F-CA09-41BF-87A9-F09A7F91A0CB @default.
- Q72101958 P2093 Q72101958-53FB7635-F93F-4965-B5E6-273F889BD5DE @default.
- Q72101958 P2093 Q72101958-6D98D764-DD49-4CD3-B35B-39450D831C1F @default.
- Q72101958 P2093 Q72101958-793F0F9E-1BEF-4BE3-B423-46AC94767CE5 @default.
- Q72101958 P2093 Q72101958-D147EC2D-478D-4C6F-9B2F-3C63F3286836 @default.
- Q72101958 P2093 Q72101958-EB872AA2-83D4-44FD-855C-1F32E54069E7 @default.
- Q72101958 P2093 Q72101958-FC420FAC-B7E0-4AA5-9213-66B47E98806A @default.
- Q72101958 P2860 Q72101958-016058D9-B7E5-424F-A637-D70B6F69F843 @default.
- Q72101958 P2860 Q72101958-0BD32A9C-725E-4EDC-86A3-A2EFB049B3E5 @default.
- Q72101958 P2860 Q72101958-1ADFD8B6-5538-46E0-AC86-F54230E4A3C7 @default.
- Q72101958 P2860 Q72101958-1EEB6E8B-2974-4AFF-BF93-8A3EFDA577C8 @default.
- Q72101958 P2860 Q72101958-2DA1FBDE-D89C-48B8-89E3-016387501E7A @default.
- Q72101958 P2860 Q72101958-4FDB4223-634F-483B-9E6C-950E0FE72903 @default.
- Q72101958 P2860 Q72101958-50C8693A-5E37-4DE4-B987-9F8AEA231393 @default.
- Q72101958 P2860 Q72101958-5263F2CC-6F75-4A74-8939-ADB4123D8DFE @default.
- Q72101958 P2860 Q72101958-615D6388-9643-4118-8F4F-771BEBB5A80C @default.
- Q72101958 P2860 Q72101958-7150553F-16A3-413D-B6EC-71E6EC1A6E38 @default.
- Q72101958 P2860 Q72101958-97D4E29C-6215-4D67-B608-A029DC528D43 @default.
- Q72101958 P2860 Q72101958-9B02B259-DE0D-4D06-B7CB-09C89AB926E3 @default.
- Q72101958 P2860 Q72101958-A6038E54-B89F-4241-BAED-59E4A2ED4AA2 @default.
- Q72101958 P2860 Q72101958-A804B95A-7013-4B1E-9454-0BCAD15C5AE2 @default.
- Q72101958 P2860 Q72101958-AB93CD59-A992-4C5D-B07A-5B52E3A61AF8 @default.
- Q72101958 P2860 Q72101958-CAEAD7F7-04AD-4740-B07A-275BAECE73D2 @default.
- Q72101958 P2860 Q72101958-E97A6307-B071-4C30-B71C-8B1C400FA687 @default.
- Q72101958 P2860 Q72101958-EA2A98A3-A9AB-486C-BB14-6EDE6882D195 @default.
- Q72101958 P2860 Q72101958-F455F6DF-5F9B-4659-9AC6-9F16F4141FF6 @default.
- Q72101958 P2888 Q72101958-E668EF2C-BD54-4301-A53B-272D34B00441 @default.
- Q72101958 P304 Q72101958-5F74BD36-914B-4C45-B0DA-5F51D43AD0F6 @default.
- Q72101958 P31 Q72101958-6D5092A9-2970-4E3A-847B-581D003CFB1C @default.
- Q72101958 P356 Q72101958-6C25281C-96A0-492E-90B4-75AA89C47658 @default.
- Q72101958 P478 Q72101958-1BE8B71B-B59B-4B33-B41C-13CDDCF2D580 @default.
- Q72101958 P577 Q72101958-CE406185-D83A-4541-AEE4-80B0EFAE1474 @default.
- Q72101958 P6179 Q72101958-62ADE044-9752-4C21-B634-02B845BEC392 @default.
- Q72101958 P698 Q72101958-94F84E94-4A9F-4B94-9655-BAEC482A15A2 @default.
- Q72101958 P921 Q72101958-2112BD4A-E505-4882-8D9F-676BEEB07E0E @default.
- Q72101958 P356 00003495-199300452-00010 @default.
- Q72101958 P698 7693424 @default.
- Q72101958 P1433 Q3040094 @default.
- Q72101958 P1476 "Postmenopausal patients with node-positive resectable breast cancer. Tamoxifen vs FEC 50 (6 cycles) vs FEC 50 (6 cycles) plus tamoxifen vs control--preliminary results of a 4-arm randomised trial. The French Adjuvant Study Group" @default.
- Q72101958 P2093 "A Monnier" @default.
- Q72101958 P2093 "D Gedouin" @default.
- Q72101958 P2093 "D Serin" @default.
- Q72101958 P2093 "E Cabarrot" @default.
- Q72101958 P2093 "F Plat" @default.
- Q72101958 P2093 "J P Gérard" @default.
- Q72101958 P2093 "J P Jacquin" @default.
- Q72101958 P2093 "M Héry" @default.
- Q72101958 P2093 "M J Goudier" @default.
- Q72101958 P2093 "M Namer" @default.
- Q72101958 P2860 Q27860916 @default.
- Q72101958 P2860 Q36530107 @default.
- Q72101958 P2860 Q38197103 @default.
- Q72101958 P2860 Q41404291 @default.
- Q72101958 P2860 Q59289818 @default.
- Q72101958 P2860 Q68514576 @default.
- Q72101958 P2860 Q68531677 @default.
- Q72101958 P2860 Q69855869 @default.
- Q72101958 P2860 Q69855963 @default.
- Q72101958 P2860 Q69859488 @default.
- Q72101958 P2860 Q69881972 @default.
- Q72101958 P2860 Q69908535 @default.
- Q72101958 P2860 Q69916062 @default.
- Q72101958 P2860 Q69916231 @default.
- Q72101958 P2860 Q70201945 @default.
- Q72101958 P2860 Q70267896 @default.
- Q72101958 P2860 Q70330922 @default.
- Q72101958 P2860 Q72580357 @default.
- Q72101958 P2860 Q93501545 @default.
- Q72101958 P2888 00003495-199300452-00010 @default.
- Q72101958 P304 "60-67" @default.
- Q72101958 P31 Q13442814 @default.
- Q72101958 P356 "10.2165/00003495-199300452-00010" @default.
- Q72101958 P478 "45 Suppl 2" @default.
- Q72101958 P577 "1993-01-01T00:00:00Z" @default.
- Q72101958 P6179 "1039382587" @default.
- Q72101958 P698 "7693424" @default.
- Q72101958 P921 Q412178 @default.